Danone击败了2025年的预期,中国的销售额强劲,提高了股息,并保持了2026年的增长目标,尽管略有倒退。 Danone beat 2025 expectations with strong sales in China, raised its dividend, and kept its 2026 growth target despite minor setbacks.

在报告2025年的结果比预期的要强之后,Danone满怀信心地进入了2026年,在中国婴儿食品和医疗营养需求强劲的驱动下,类似的销售额上升了4.5%,现金流量超过预测。 Danone entered 2026 with confidence after reporting stronger-than-expected 2025 results, with like-for-like sales up 4.5% and cash flow exceeding forecasts, driven by strong demand for baby food and medical nutrition in China. 尽管报告的销售额略有下降,而且没有经常损失,但该公司重申其2026年的类似销售额增长目标,即达到3-5%的类似销售额,指出正在使用的婴儿配方奶粉召回与小硫化物污染相关的财务影响仍然不具有物质意义。 Despite a slight drop in reported sales and a nonrecurring loss, the company reiterated its 2026 growth target of 3-5% like-for-like sales, stating the financial impact of ongoing infant formula recalls linked to cereulide contamination remains not material. 该公司还提高了4.7%的红利。 The company also raised its dividend by 4.7%.